| 000 | 01684 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515051140.0 | ||
| 264 | 0 | _c20070119 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm060189a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMuchmore, Steven W | |
| 245 | 0 | 0 |
_aCrystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cNov 2006 |
||
| 300 |
_a6726-31 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine Kinase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aMorpholines _xchemistry |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aPyrimidines _xchemistry |
| 650 | 0 | 4 |
_aToxoplasma _xenzymology |
| 650 | 0 | 4 |
_aTubercidin _xanalogs & derivatives |
| 700 | 1 | _aSmith, Richard A | |
| 700 | 1 | _aStewart, Andrew O | |
| 700 | 1 | _aCowart, Marlon D | |
| 700 | 1 | _aGomtsyan, Arthur | |
| 700 | 1 | _aMatulenko, Mark A | |
| 700 | 1 | _aYu, Haixia | |
| 700 | 1 | _aSeverin, Jean M | |
| 700 | 1 | _aBhagwat, Shripad S | |
| 700 | 1 | _aLee, Chih-Hung | |
| 700 | 1 | _aKowaluk, Elizabeth A | |
| 700 | 1 | _aJarvis, Michael F | |
| 700 | 1 | _aJakob, Clarissa L | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 49 _gno. 23 _gp. 6726-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm060189a _zAvailable from publisher's website |
| 999 |
_c16723795 _d16723795 |
||